什么对全部放射治疗的剂量分配,每日部体积变化或残留设置错误有更大的影响?
Yuki Aoyama1, Tetsuya Tomida1, Shogo Tsunemine1
1Radiation and Proton Therapy Center, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Shizuoka 411-8777, Japan.
Journal of medical imaging and radiation sciences
|May 12, 2025
概括
部体积变化对头部癌症患者的辐射剂量分配有显著的影响,而不是设置错误. 监测这些变化对于及时重新规划治疗和优化放射治疗结果至关重要.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
背景情况:
- 头部放射治疗需要重新规划治疗,因为解剖学变化.
- 精确的ART®剂量计算取决于兆电压CT,需要监测体积变化.
- 最佳的重新计划时间被未知的因素阻碍,这些因素会影响音量变化和设置错误.
研究的目的:
- 确定影响头部放射治疗剂量分配的主要影响因素.
- 为了确定体积变化与设置错误对辐射剂量分配的影响.
主要方法:
- 研究了30名接受强度调节放射治疗的头癌患者.
- 计算相关系数以评估与体积变化和设置错误相关的剂量分配差异.
- 体积变化被定义为部结构体积的变化;设置错误包括残留的脊椎和肩部位置差异.
主要成果:
- 部体积变化与剂量指标有很强的负相关性:D95%_CTV -0.71,Dmean_CTV -0.68,Dmean_PTV -0.63.
- 辐射剂量和设置错误之间的相关性不如体积变化的相关性那么显著.
结论:
- 部体积变化对辐射剂量分布的影响比剩余设置错误更大.
- 这些发现强调了跟踪解剖变异对于有效的头癌治疗计划的重要性.
相关概念视频
Biological Effects of Radiation
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
Drug Distribution: Tissue Binding
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...


